Available now: Open-access interviews with experts on the COVID-19 pandemic: epidemiology, virus biology and possible vaccines and treatmentsView All
Prof. Dr. Christian Buchholz Paul-Ehrlich-Institut, Germany1 Talk
Christian Buchholz started his scientific career at the Max-Planck-Institut for Biochemistry where he obtained his PhD in the Department for Virology in 1993. He performed postdoctoral studies at the Institute for Molecular Biology of the University of Zurich and the Centre for Protein Engineering at the MRC in Cambridge, UK.... read moreHe leads the Section of Molecular Biotechnology and Gene Therapy at the Paul-Ehrlich-Institut since 1999 and became Associate Professor for Biochemistry at the Goethe-University in Frankfurt in 2007.
His research interests focus on the engineering of the surface of viral vectors to understand the molecular events during viral cell entry and to improve their applicability in modern molecular medicine. He was the first to demonstrate that the surface of retroviruses can be used as scaffold to display libraries of antibody molecules or protease substrates. More recently, his team succeeded in engineering receptor-targeted lentiviral and AAV vectors. These vectors are modified in their receptor usage being blind for their natural receptor and instead using a cell surface molecule of interest for cell entry. They offer great potential for applications in functional genomics and gene therapy.